supported in part by grants from the National Key Research and Development Program of China(No.2017YFA0505202);the National Basic Research Program of China(973 Program)(No.2015CB910403);the National Natural Science Foundation of China(Nos.81570118,81700475,81570112,81670139,and 21602133);the National Natural Science Foundation Youths of China(No.81700157);Innovative research team of high-level local universities in Shanghai(SSMU-ZDCX20181202).
The kinase FLT3 internal tandem duplication(FLT3-ITD)is related to poor clinical outcomes of acute myeloid leukemia(AML).FLT3 inhibitors have provided novel strategies for the treatment of FLT3-ITD-positive AML.But th...
supported by grants from The National Natural Science Foundation of China(81070392,81222005,81070435);Beijing Natural Science Foundation Projects(5122036);National Basic Research Program of China(2010CB911904,2012AA020206)~~